Preferred Pharmaceuticals Inc

Stason Pharmaceuticals is a US-based pharmaceutical company headquartered in Irvine, California, specializing in the development of partnerships and drugs within oncology, renal, and orphan indications. With its contract service divisions, MPhS and Western PharmSci, the company provides comprehensive contract packaging, analytical testing, and CDMO services to drug-development companies, supporting both clinical trial materials and commercial production of high-potency products. Since entering the US generic market in 1994, Stason has established a diverse portfolio and a global network of distributors. The company combines its advanced manufacturing capabilities, including high containment facilities, with strategic alliances across the US, Canada, Europe, and Asia to foster innovation and ensure compliance with industry standards. Generated from the website

AVANIR Pharmaceuticals is engaged in the research, discovery, development and licensing of innovative drug products used in the treatment of chronic diseases. Its product candidates address therapeutic markets that include the central nervous system, atherosclerosis, inflammatory diseases and infectious diseases. Its research and drug discovery programs are focused primarily on small molecules that can be taken orally as therapeutic treatments. The company's lead product candidate, Neurodex, is used for the treatment of Involuntary Emotional Expression Disorder, a condition also known as pseudobulbar affect or emotional lability. Also in clinical development is AVP 13358, a selective cytokine inhibitor. AVANIR was founded in 1988 and has corporate headquarters in San Diego. Its common shares trade on the NASDAQ under the ticker symbol AVNR.

Amphastar Pharmaceutical is pursuing Global Licensing and is registered and inspected regularly by the FDA. Amphastar Pharmaceuticals is a generic and specialty pharmaceutical company that focuses on the research, development, manufacture and marketing of generic and specialty pharmaceutical parenteral products (products for nutrition through intravenous drip). In 1998 Amphastar Pharmaceutical acquired International Medications Systems, Limited, a manufacturer of sterile injectable pharmaceuticals for domestic and international markets. Amphastar Pharmaceutical expanded again in 2003 through the acquisition of Armstrong Pharmaceuticals, a manufacturer of metered-dose inhalers and nasal spray products. The company was founded in 1996 maintains an excellent regulatory/cGMP compliance record.